Pharmacy Update
Disclaimer: We are getting frequent COVID-related questions about drug concerns and potential interactions. This information is as of July 29, 2020. We will do our best to keep you up to date with this ever evolving situation. This is the most update information at the time of publication.
Note: There are no Food and Drug Administration
(FDA) approved therapies for treatment or prevention of COVID-19. If at all possible, it is best to have patients enrolled in a clinical trial.
In this issue:
Hydroxychloroquine with or without Azithromycin in Mild to Moderate Hospitalized COVID-19 in Brazil
ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 - Preliminary Report
Update: Expanded FDA/CDC Warning on Methanol Contaminated Hand Sanitizer
FDA Requiring Labeling Changes for Opioid Pain Medicines, Opioid Use Disorder Medicines Regarding Naloxone
